News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Becton, Dickinson and Company (BDX) Board Declares Dividend


7/22/2014 2:24:44 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

FRANKLIN LAKES, N.J., July 22, 2014 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of 54.5 cents per common share payable on September 30, 2014 to holders of record on September 9, 2014. The indicated annual dividend rate is $2.18 per share.

About BD
BD is a leading medical technology company that partners with customers and stakeholders to address many of the world's most pressing and evolving health needs. Our innovative solutions are focused on improving drug delivery, enhancing the diagnosis of infectious diseases and cancers, supporting the management of diabetes and advancing cellular research. We are nearly 30,000 associates in 50 countries who strive to fulfill our purpose of "Helping all people live healthy lives" by advancing the quality, accessibility, safety and affordability of healthcare around the world. For more information, please visit www.bd.com.

Contact:
Monique N. Dolecki, Investor Relations 201-847-5378
Alyssa J. Zeff, Corporate Communications 201-847-4358

SOURCE BD (Becton, Dickinson and Company)

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES